PURPOSE: In this study the potential of diphenhydramine in reducing respectively preventing vertigo and nausea induced by the ultra-high static magnetic field at 7 T was evaluated. MATERIALS AND METHODS: In a prospective, double blinded, placebo controlled, cross-over randomized study the sensations of 34 volunteers before, during and after exposure to the static magnetic field with and without drug respectively placebo administration were quantified. Fast table motion was applied to increase the incidence of otherwise sparse reports of field related sensations. RESULTS: The strength of vertigo can be reduced by the application of diphenhydramine. CONCLUSION:Diphenhydramine, even at a low dose, reduces the strength of vertigo at ultra-high static magnetic fields, may be used preventively, and could pave the way to even higher field strength.
RCT Entities:
PURPOSE: In this study the potential of diphenhydramine in reducing respectively preventing vertigo and nausea induced by the ultra-high static magnetic field at 7 T was evaluated. MATERIALS AND METHODS: In a prospective, double blinded, placebo controlled, cross-over randomized study the sensations of 34 volunteers before, during and after exposure to the static magnetic field with and without drug respectively placebo administration were quantified. Fast table motion was applied to increase the incidence of otherwise sparse reports of field related sensations. RESULTS: The strength of vertigo can be reduced by the application of diphenhydramine. CONCLUSION:Diphenhydramine, even at a low dose, reduces the strength of vertigo at ultra-high static magnetic fields, may be used preventively, and could pave the way to even higher field strength.
Authors: Jens M Theysohn; Oliver Kraff; Kristina Eilers; Dorian Andrade; Marcus Gerwig; Dagmar Timmann; Franz Schmitt; Mark E Ladd; Susanne C Ladd; Andreas K Bitz Journal: PLoS One Date: 2014-03-21 Impact factor: 3.240